B37.81
Candidal esophagitis
Clinical Classification Guidelines
Medical Intelligence & Overview
Candidal esophagitis, also known as fungal esophagitis, is an infection of the esophagus caused by the Candida species, most commonly Candida albicans. This condition often affects individuals with weakened immune systems or those undergoing treatments that lower immunity. Recognized under ICD-10 code B37.81, candidal esophagitis can cause discomfort and difficulty swallowing, and requires proper diagnosis and management to prevent complications.
Causes & Symptoms
Clinical Causes: Immunosuppression due to conditions such as HIV/AIDS Use of immunosuppressive medications including corticosteroids Chemotherapy or cancer treatments that weaken the immune system Prolonged use of antibiotics which disturb normal flora balance Diabetes mellitus with high blood sugar levels Smoking and heavy alcohol consumption Poor oral hygiene and wearing dentures Presence of other chronic diseases that impair immunity
Key Symptoms: Difficulty swallowing (dysphagia) Pain or discomfort behind the breastbone (retrosternal pain) Odynophagia (pain when swallowing) Feeling of something stuck in the throat Chest pain that may worsen with swallowing Nausea or vomiting in some cases Taste changes or a sensation of fullness Fever, particularly if the infection becomes severe
Diagnostic & Treatment
Diagnosis Path: Diagnosis of candidal esophagitis typically involves a combination of clinical assessment and diagnostic tests. An endoscopy allows visualization of white patches or plaques on the esophageal lining. Biopsies taken during endoscopy can be examined microscopically to confirm the presence of Candida organisms. Additionally, samples such as tissue scrapings or brushings may be cultured to identify Candida species. Imaging studies are generally not primary but can be helpful if complications are suspected.
Treatment Protocols: Treatment generally involves antifungal medications aimed at eradicating the infection. The most common treatments include oral or intravenous antifungals such as fluconazole, itraconazole, or amphotericin B depending on the severity and patient factors. Managing underlying conditions that contribute to immunosuppression is crucial for recovery. In cases related to dentures or oral hygiene issues, improving dental care practices can help prevent recurrence. Follow-up with healthcare providers is essential to monitor response to treatment and adjust therapy as needed.
Clinical Advice & FAQs
Billing Guidance
Is B37.81 a billable ICD-10 code?
Yes, B37.81 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report B37.81?
Clinical documentation must specify the nature of Candidal esophagitis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
